Bernardi M, Calandra S, Colantoni A, Trevisani F, Raimondo M L, Sica G, Schepis F, Mandini M, Simoni P, Contin M, Raimondo G
Dipartimento di Medicina Interna, Cardioangiologia, Epatologia, University of Bologna, Italy.
Hepatology. 1998 Jan;27(1):28-34. doi: 10.1002/hep.510270106.
Prolonged Q-T interval predicts severe arrhythmias and sudden death, and has been shown to occur in alcoholic liver disease and cirrhotic patients who are candidates for liver transplantation. This study first evaluated the prevalence of prolonged Q-T interval in a large population of unselected patients with cirrhosis, and assessed the relationship between abnormal Q-T, etiology, and severity of liver disease and mortality of patients. Possible causes of Q-T abnormality were also explored. Ninety-four patients with cirrhosis without overt heart disease and 37 control subjects with mild chronic active hepatitis were enrolled. Rate-corrected Q-T interval (Q-Tc) was assessed along with routine liver tests, Child-Pugh score, serum bile salts, electrolytes and creatinine, plasma renin activity, aldosterone, norepinephrine, atrial natriuretic factor and, gonadal hormones. Q-Tc was longer in patients with cirrhosis than in controls (440.3 +/- 3.2 vs. 393.6 +/- 3.7 ms; P < .001) and prolonged (> 440 ms) in 44 patients (46.8%) and 2 controls (5.4%; P < .001). Q-Tc length was not influenced by the etiology of cirrhosis and correlated with Child-Pugh score (r = .53; P < .001), liver tests such as prothrombin activity, and serum concentrations of albumin and bilirubin, plasma bile salts, and plasma norepinephrine. Multivariate analysis showed that only Child-Pugh score and plasma norepinephrine were independently correlated with Q-Tc duration. Over a median follow-up period of 19 months (range, 2-33 months), patients with Q-Tc longer than 440 ms had a significantly lower survival rate than those with normal Q-Tc. Q-T interval is frequently prolonged in patients with cirrhosis, regardless the etiology of the disease, worsens in parallel with the severity of the disease, and may have an important prognostic meaning. In addition to other undefined factors related to the severity of cirrhosis, sympathoadrenergic hyperactivity may play a pathogenetic role.
QT间期延长可预测严重心律失常和猝死,且已证实在酒精性肝病患者以及适合肝移植的肝硬化患者中会出现QT间期延长。本研究首先评估了一大群未经挑选的肝硬化患者中QT间期延长的患病率,并评估了QT异常、肝病病因、严重程度与患者死亡率之间的关系。还探讨了QT异常的可能原因。纳入了94例无明显心脏病的肝硬化患者和37例轻度慢性活动性肝炎对照受试者。同时评估了校正心率后的QT间期(QTc)以及常规肝功能检查、Child-Pugh评分、血清胆汁盐、电解质和肌酐、血浆肾素活性、醛固酮、去甲肾上腺素、心房利钠因子和性腺激素。肝硬化患者的QTc长于对照组(440.3±3.2 vs. 393.6±3.7毫秒;P<.001),44例患者(46.8%)QTc延长(>440毫秒),2例对照受试者(5.4%)QTc延长(P<.001)。QTc长度不受肝硬化病因的影响,与Child-Pugh评分(r=.53;P<.001)、诸如凝血酶原活性等肝功能检查以及白蛋白、胆红素、血浆胆汁盐和血浆去甲肾上腺素的血清浓度相关。多变量分析显示,只有Child-Pugh评分和血浆去甲肾上腺素与QTc持续时间独立相关。在中位随访期19个月(范围2-33个月)内,QTc长于440毫秒的患者生存率显著低于QTc正常的患者。肝硬化患者的QT间期经常延长,无论疾病病因如何,且随疾病严重程度加重,可能具有重要的预后意义。除了与肝硬化严重程度相关的其他未明确因素外,交感神经活性亢进可能起致病作用。